Gilead will charge a higher price for its Covid-19 drug remdesivir for most patients in the U.S. and a lower price for the rest of the developed world

Gilead will charge a higher price for its Covid-19 drug remdesivir for most patients in the U.S. and a lower price for the rest of the developed world https://t.co/gQ5GFZwCqf

— The Wall Street Journal (@WSJ) July 3, 2020